Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lokiarchaeum ossiferum B36 proteomic analysis

ABSTRACT: Proteomic expression analysis of Ca. Lokiarchaeum ossiferum, strain B36, grown using casein hydrolysate as the main carbon source under anaerobic conditions

INSTRUMENT(S):

ORGANISM(S): Candidatus Lokiarchaeum Sp. B-35

SUBMITTER: Markus Hartl

LAB HEAD: Christa Schleper

PROVIDER: PXD055577 | Pride | 2026-01-14

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20230508_E4_NEO1_Rodrigues_Schleper_MPLGmbH_Academic_MPLID23074_s3_DIA_1ug.raw	Raw
	20230508_E4_NEO1_Rodrigues_Schleper_MPLGmbH_Academic_MPLID23074_s4_DIA_1ug.raw	Raw
	ID_23074_s3_s4_DIA_search.sne	Other
	MsReport_result.zip	Other
	Raw_file_experiment_list_RP.xlsx	Xlsx

Items per page:

1 - 5 of 5

Similar Datasets

Lokiarchaeum ossiferum B35 proteomic analysis

Project description:Proteomic expression analysis of Ca. Lokiarchaeum ossiferum, strain B35, grown using casein hydrolysate as the main carbon source under anaerobic conditions

2024-04-11 | PXD047696 | Pride

Peptide fingerprinting of eluates obtained from phosphatase inhibitor beads (PIBs)

Project description:Peptide fingerprinting to verify the efficacy of phosphatase inhibitor beads (PIBs) for capturing Spodoptera frugiperda (Sf9) phosphatases of the PP2A family.

2025-03-13 | PXD045891 | Pride

Identification of global proteome changes upon rapalog-induced tethering of WIPI2 to the mitochondrial outer membrane in wild-type or NIX/BNIP3 DKO HeLa cells

Project description:We aimed to identify proteins that would be turned over upon artificial tethering of WIPI2 to the mitochondrial surface upon rapalog treatment, using the FIS1-FRB plus FKBP-GFP-WIPI2 tethering system. We had previously observed that this induces mitophagy based on flow cytometry analysis of the mt-mKeima probe. Here, we aimed to identify which proteins are degraded upon 24 h Rapalog treatment and verified whether there was an enrichment of mitochondrial proteins being selectively turned over by mitophagy under these conditions in wild-type and NIX/BNIP3 double-knockout HeLa cells.

2025-01-30 | PXD060363 | Pride

Identification of global proteome changes upon DFP treatment of HeLa cells

Project description:We aimed to identify proteins that would be turned over upon DFP treatment, a small molecule that mimicks hypoxia treatment and which induces NIX/BNIP3 mitophagy. We aimed to identify which proteins are degraded upon 24 h DFP treatment and verified whether there was an enrichment of mitochondrial proteins being selectively turned over by mitophagy under these conditions.

2025-01-30 | PXD060356 | Pride

Peptide fingerprinting of purified recombinant human PHLPP2

Project description:Peptide fingerprinting to establish whether there is any contaminating phosphatase(s) in the purified protein.

2025-03-13 | PXD045978 | Pride

Quantitative proteomics to systematically assess protein changes after HUWE1 knockout, in RAW264.7-Dox-Cas9.

Project description:Quantitative proteomics to systematically assess protein changes after HUWE1 knockout, in RAW264.7-Dox-Cas9.

2023-03-22 | PXD036715 | Pride

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of AR function in advanced prostate cancer

Project description:The androgen receptor (AR) is a critical driver of prostate cancer (PCa). To study regulators of AR protein levels and oncogenic activity, we created the first live cell quantitative endogenous AR fluorescent reporters. Leveraging this novel AR reporter, we performed genome-scale CRISPRi flow cytometry sorting screens to systematically identify genes that modulate AR protein levels. We identified and validated known AR protein regulators including HOXB13 and GATA2 and also unexpected top hits including PTGES3, a poorly characterized gene in PCa. PTGES3 repression resulted in loss of AR protein, cell cycle arrest, and cell death in AR-driven PCa models. PTGES3 is not a commonly essential gene, and our data nominate it as a prime PCa drug target. Clinically, analysis of PCa data demonstrate that PTGES3 expression is associated with AR directed therapy resistance. Mechanistically, we show PTGES3 binds directly to AR, forms a protein complex with AR in the nucleus, regulates AR protein stability in vitro and in vivo and modulates AR function in the nucleus at AR target genes. Lastly using a disulfide tethering fragment screen, we developed a PTGES3 covalent inhibitor that blocks the PTGES3/AR interaction and represses AR signaling in PCa cells, suggesting PTGES3 inhibitors may be a next generation AR-targeting therapeutic strategy that can overcome known mechanisms of resistance to existing AR-directed therapies in PCa.

2025-08-08 | PXD066297 | Pride

Cytoplasmic mRNA decay controlling inflammatory gene expression is determined by pre-mRNA fate decision

Project description:The fidelity of immune responses depends on a timely controlled and selective mRNA degradation that is largely driven by RNA-binding proteins (RBPs). It remains unclear whether the selection of an individual mRNA molecule for degradation is governed by stochastic or directed processes. Here, we show that tristetraprolin (TTP, also known as ZFP36), an essential anti-inflammatory RBP, destabilizes target mRNAs via a hierarchical molecular assembly. The formation of the assembly strictly relies on the interaction of TTP with RNA. The TTP homolog ZFP36L1 exhibits similar requirements, indicating a broader relevance of this regulatory program. Unexpectedly, the assembly of the cytoplasmic mRNA-destabilization complex is licensed in the nucleus by TTP binding to pre-mRNA, while cytoplasmic mRNA does not constitute a de novo TTP target. Hence, the fate of an inflammation-induced mRNA is decided concomitantly with its synthesis. This mechanism prevents the translation of excessive and potentially harmful inflammation mediators, irrespective of transcription.

2025-01-07 | PXD051662 | Pride

PSCK9 knockdown in EndoC-bH1 cells at 72 h (DIA proteomics experiment)

Project description:EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 72 hours. The experiment was powered based PCSK9 knockdown in a pilot experiment. Sample size: 12x12.

2022-04-07 | PXD027911 | Pride

Identification of differentially expressed proteins in mouse testes by LC-MSMS

Project description:Identify the differentially expressed proteins between control and Exosc10 conditional knockout testes.

2025-09-30 | PXD052908 | Pride